The title 'Registered Nurse' (also known in the state of Victoria as a 'Division 1 Nurse') is granted to a Nurse who has successfully completed a board approved course in the field of nursing, as outlined by education and registration standards defined by the NMBA.
LINZESSÂ® (linaclotide) is a prescription medication used in adults to treat irritable bowel syndrome with constipation (IBSâC) and chronic idiopathic constipation (CIC). Idiopathic means the cause of the constipation is unknown. It is not known if LINZESS is safe and effective in children.
Linzess is a drug marketed by Forest Labs Llc and is included in one NDA. There are nine patents protecting this drug and one Paragraph IV challenge. This drug has one hundred and sixteen patent family members in thirty-four countries. The generic ingredient in LINZESS is linaclotide. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the linaclotide profile page.